Northfield, Ill. (June 25, 2025)—Immunohistochemistry (IHC) can serve as a powerful surrogate for genetic testing in the diagnosis of soft tissue tumors. In a new review from the College of…
Category: chemistry
SGLT-2 Inhibitors and Serious Liver Events in Patients With Cirrhosis
This retrospective cohort study was conducted using data from TriNetX, a multi-institutional health research network. Using the TriNetX platform, we accessed deidentified electronic health records from over 212 million patients across 120 major health care organizations.9 The built-in analytic functions of TriNetX enable patient-level analyses while ensuring that only population-level data are reported.
This study was approved by WCG Clinical, which granted a waiver to TriNetX as a federated network and was deemed exempt from informed consent owing to the use of existing, non–human participant data that were deidentified per the US Health Insurance Portability and Accountability Act privacy rule. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
We included patients with cirrhosis (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] codes K74.6 and K74.69), who were taking furosemide (RxNorm [National Library of Medicine] code 4603) and spironolactone (RxNorm code 9997) between January 2013 and July 2021. For patients receiving an SGLT-2 inhibitor (Anatomical Therapeutic Chemical code A10BK), the index event was defined as the date on which they were concurrently prescribed spironolactone, furosemide, and an SGLT-2 inhibitor. For the control group, the index event was the date on which they were prescribed concurrent spironolactone and furosemide but not an SGLT-2 inhibitor. Each patient was followed up for 3 years from the index event, with follow-up ending on July 11, 2024.
Artificial photosynthesis system surpasses key efficiency benchmark for direct solar-to-hydrogen conversion
A research team affiliated with UNIST has introduced a cutting-edge modular artificial leaf that simultaneously meets high efficiency, long-term stability, and scalability requirements—marking a major step forward in green hydrogen production technology essential for achieving carbon neutrality.
Jointly led by Professors Jae Sung Lee, Sang Il Seok, and Ji-Wook Jang from the School of Energy and Chemical Engineering, this innovative system mimics natural leaves by producing hydrogen solely from sunlight and water, without requiring external power sources or emitting carbon dioxide during the process—a clean hydrogen production method. The study is published in Nature Communications.
Unlike conventional photovoltaic-electrochemical (PV-EC) systems, which generate electricity before producing hydrogen, this direct solar-to-chemical conversion approach reduces losses associated with electrical resistance and minimizes installation footprint. However, prior challenges related to low efficiency, durability, and scalability hindered commercial deployment.
Nanodomains hold the key to next-generation solar cells, researchers find
A new study, published in Nature Nanotechnology and featured on the journal’s front cover this month, has uncovered insights into the tiny structures that could take solar energy to the next level.
Researchers from the Department of Chemical Engineering and Biotechnology (CEB) have found that dynamic nanodomains within lead halide perovskites—materials at the forefront of solar cell innovation—hold a key to boosting their efficiency and stability. The findings reveal the nature of these microscopic structures, and how they impact the way electrons are energized by light and transported through the material, offering insights into more efficient solar cells.
The study was led by Milos Dubajic and Professor Sam Stranks from the Optoelectronic Materials and Device Spectroscopy Group at CEB, in collaboration with an international network, with key contributions from Imperial College London, UNSW Sydney, Colorado State University, ANSTO Sydney, and synchrotron facilities in Australia, the UK, and Germany.
Mist and sea spray create unique conditions for urea to form from simple gases
Urea is considered a possible key molecule in the origin of life. ETH researchers have discovered a previously unknown way in which this building block can form spontaneously on aqueous surfaces without the need for any additional energy.
Urea is one of the most important industrial chemicals produced worldwide. It is used as a fertilizer, for the production of synthetic resins and explosives and as a fuel additive for cleaning car exhaust gases. Urea is also believed to be a potential key building block for the formation of biological molecules such as RNA and DNA in connection with the question of the origin of life.
Until now, the origin of urea itself on early Earth has not been conclusively clarified.
Quantum simulation of chemical dynamics achieved for the first time
Researchers at the University of Sydney have successfully performed a quantum simulation of chemical dynamics with real molecules for the first time, marking a significant milestone in the application of quantum computing to chemistry and medicine.
Understanding in real time how atoms interact to form new compounds or interact with light has long been expected as a potential application of quantum technology. Now, quantum chemist Professor Ivan Kassal and Physics Horizon Fellow Dr Tingrei Tan, have shown it is possible using a quantum machine at the University of Sydney.
The innovative work leverages a novel, highly resource-efficient encoding scheme implemented on a trapped-ion quantum computer in the University of Sydney Nanoscience Hub, with implications that could help transform medicine, energy and materials science.
University of Sydney scientists have made a big step towards future design of treatments for skin cancer or improved sunscreen by modelling photoactive chemical dynamics with a quantum computer.
Enzyme-based plastics recycling at an industrial scale could be cost-effective, analysis finds
A successful collaboration involving a trio of research institutions has yielded a roadmap toward an economically viable process for using enzymes to recycle plastics.
The researchers, from the National Renewable Energy Laboratory (NREL), the University of Massachusetts Lowell, and the University of Portsmouth in England, previously partnered on the biological engineering of improved PETase enzymes that can break down polyethylene terephthalate (PET). With its low manufacturing cost and excellent material properties, PET is used extensively in single-use packaging, soda bottles, and textiles.
The new study, published in Nature Chemical Engineering, combines previous fundamental research with advanced chemical engineering, process development, and techno-economic analysis to lay the blueprints for enzyme-based PET recycling at an industrial scale.
New hybrid quantum–classical computing approach used to study chemical systems
Caltech professor of chemistry Sandeep Sharma and colleagues from IBM and the RIKEN Center for Computational Science in Japan are giving us a glimpse of the future of computing. The team has used quantum computing in combination with classical distributed computing to attack a notably challenging problem in quantum chemistry: determining the electronic energy levels of a relatively complex molecule.
The work demonstrates the promise of such a quantum–classical hybrid approach for advancing not only quantum chemistry, but also fields such as materials science, nanotechnology, and drug discovery, where insight into the electronic fingerprint of materials can reveal how they will behave.
“We have shown that you can take classical algorithms that run on high-performance classical computers and combine them with quantum algorithms that run on quantum computers to get useful chemical results,” says Sharma, a new member of the Caltech faculty whose work focuses on developing algorithms to study quantum chemical systems. “We call this quantum-centric supercomputing.”
Nanobody hitchhikers boost immunotherapy potency in cancer treatment
Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer.
The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING Agonist Conjugates,” is published in Nature Biomedical Engineering.
Immunotherapy is revolutionizing cancer treatment, but few patients benefit from the treatment, according to researchers. However, Wilson and his Immunoengineering Lab at Vanderbilt, along with collaborators at Vanderbilt University Medical Center, SOMBS, and the College of Arts and Sciences, aim to solve this problem.
Insulin on edge: Study identifies stress-triggered gene behind diabetes
Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages pancreatic β-cells—the cells responsible for insulin production and blood sugar control—pushing them toward dysfunction. The findings highlight a promising new target for early intervention in type 2 diabetes. The study is published in the Journal of Biological Chemistry.
While many factors can contribute to type 2 diabetes, lifestyle, especially diet, plays a major role in its onset. Genetics matter, but poor eating habits can greatly increase the risk of developing what is now often called a “silent epidemic.”
“Type 2 diabetes occurs when pancreatic β-cells, which secrete insulin to regulate blood glucose, become impaired due to prolonged stress caused by poor dietary habits, a condition known as oxidative stress,” said Naoki Harada, an associate professor at Osaka Metropolitan University’s Graduate School of Agriculture and lead author of this study.